NCT03871140

Brief Summary

Ultrasound (US) as first-line imaging technology in detecting focal liver lesions,also plays a crucial role in evaluating image and guiding ablation which is the main treatment for liver lesions. However, the effect of US in diagnosing liver lesions is challenged by several factors including being highly dependent on doctor's experience, low signal-to-noise ratio, low resolution for lesion feature,large error from thermal field evaluation during the process of ablation and so on. Therefore, it is of great significance to construct an intelligent US analysis system depending on the digital information technology. Basing on these problems,the following research will be involved in our project: 1) US database of liver lesions with seamless connection to Picture Archiving and Communication Systems (PACS) will be developed, with the aim to provide standard data for intelligent US analysis. 2) Deep learning model for accurate segmentation, detection and classification of liver lesions on US images will be studied. Then automatic extraction, selection and analysis of liver lesion ultrasound features and the intelligent US diagnosis for liver lesions will be realized. 3) Proposing a clustering model with deep image features, and depicting the similarity measurement of liver cancer, which can be furthered used to link the liver cancer feature to optimal ablation parameters. The intelligent decision-making system for quantifying thermal ablation will be established. 4) Regression algorithm and Generative Adversarial Nets will be developed to extract the image features of liver cancer which will predict risk factors after US-guided thermal ablation.Based on the above researches, it is of great value to establish an intelligent focal liver lesion US diagnosis system involving intelligent diagnosis,personalized ablation strategy and accurate prognosis evaluation, improving the level of accurate diagnosis and treatment of liver lesions.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
10,000

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2017

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2017

Completed
1.3 years until next milestone

First Submitted

Initial submission to the registry

April 29, 2018

Completed
11 months until next milestone

First Posted

Study publicly available on registry

March 12, 2019

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2020

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2021

Completed
Last Updated

March 12, 2019

Status Verified

April 1, 2018

Enrollment Period

4 years

First QC Date

April 29, 2018

Last Update Submit

March 11, 2019

Conditions

Outcome Measures

Primary Outcomes (3)

  • AUC value

    Area under the receiver operating characteristic (ROC) curve (AUC)

    through study completion, an average of 3 year

  • specificity

    diagnosis specificity of intelligent ultrasound analysis

    through study completion, an average of 3 year

  • sensitivity

    diagnosis sensitivity of intelligent ultrasound analysis

    through study completion, an average of 3 year

Interventions

therre is no intervention diagnosis or treatment for patients

Eligibility Criteria

Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

patients with focal liver lesions

You may qualify if:

  • clear ultrasound imaging of focal liver lesions including malignant liver tumors such as hepatocellular carcinoma, metastatic liver cancer and benigh liver tumors such as hemangioma and focal nodular hyperplasia and so on can be acquired.
  • clear ultrasound imaging of liver tissues backgroud without lesions can be acquired.
  • disease history and pathological diagnosis of the lesions can be acquired.

You may not qualify if:

  • patients unsuitable for ultrasound san
  • patients counldn't provide disease history such as hepatitis, alcohol intake and so on
  • patients without pathological results

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Chinese PLA General Hospital

Beijing, Beijing Municipality, 100853, China

RECRUITING

Related Publications (2)

  • Du Z, Fan F, Ma J, Liu J, Yan X, Chen X, Dong Y, Wu J, Ding W, Zhao Q, Wang Y, Zhang G, Yu J, Liang P. Development and validation of an ultrasound-based interpretable machine learning model for the classification of </=3 cm hepatocellular carcinoma: a multicentre retrospective diagnostic study. EClinicalMedicine. 2025 Feb 13;81:103098. doi: 10.1016/j.eclinm.2025.103098. eCollection 2025 Mar.

  • Yang Y, Cairang Y, Jiang T, Zhou J, Zhang L, Qi B, Ma S, Tang L, Xu D, Bu L, Bu R, Jing X, Wang H, Zhou Z, Zhao C, Luo B, Liu L, Guo J, Nima Y, Hua G, Wa Z, Zhang Y, Zhou G, Jiang W, Wang C, De Y, Yu X, Cheng Z, Han Z, Liu F, Dou J, Feng H, Wu C, Wang R, Hu J, Yang Q, Luo Y, Wu J, Fan H, Liang P, Yu J. Ultrasound identification of hepatic echinococcosis using a deep convolutional neural network model in China: a retrospective, large-scale, multicentre, diagnostic accuracy study. Lancet Digit Health. 2023 Aug;5(8):e503-e514. doi: 10.1016/S2589-7500(23)00091-2.

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Prof

Study Record Dates

First Submitted

April 29, 2018

First Posted

March 12, 2019

Study Start

January 1, 2017

Primary Completion

December 30, 2020

Study Completion

December 30, 2021

Last Updated

March 12, 2019

Record last verified: 2018-04

Locations